Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction.
e11 - e18
MetadataShow full item record
Testing of platelet function is central to the cardiovascular phenotyping of genetically modified mice. Traditional platelet function tests have been developed primarily for testing human samples and the volumes required make them highly unsuitable for the testing of mouse platelets. This limits research in this area. To address this problem, we have developed a miniaturized whole blood aggregometry assay, based on a readily accessible 96-well plate format coupled with quantification of single platelet depletion by flow cytometric analysis. Using this approach, we observed a concentration-dependent loss of single platelets in blood exposed to arachidonic acid, collagen, U46619 or protease activated receptor 4 activating peptide. This loss was sensitive to well-established antiplatelet agents and genetic manipulation of platelet activation pathways. Observations were more deeply analyzed by flow cytometric imaging, confocal imaging, and measurement of platelet releasates. Phenotypic analysis of the reactivity of platelets taken from mice lacking intercellular adhesion molecule (ICAM)-1 identified a marked decrease in fibrinogen-dependent platelet-monocyte interactions, especially under inflammatory conditions. Such findings exemplify the value of screening platelet phenotypes of genetically modified mice and shed further light upon the roles and interactions of platelets in inflammation.
AuthorsArmstrong, PC; Kirkby, NS; Chan, MV; Finsterbusch, M; Hogg, N; Nourshargh, S; Warner, TD
- College Publications 
Showing items related by title, author, creator and subject.
Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time. Garner, SF; Furnell, A; Kahan, BC; Jones, CI; Attwood, A; Harrison, P; Kelly, AM; Goodall, AH; Cardigan, R; Ouwehand, WH (2016-12-21)BACKGROUND AND OBJECTIVES: Platelet function shows significant inheritance that is at least partially genetically controlled. There is also evidence that the platelet response is stable over time, but there are few studies ...
Kaudewitz, D; Skroblin, P; Bender, LH; Barwari, T; Willeit, P; Pechlaner, R; Sunderland, NP; Willeit, K; Morton, AC; Armstrong, PC;... (American Heart Association, Inc., 2015-12-08)RATIONALE: Platelets shed microRNAs (miRNAs). Plasma miRNAs change on platelet inhibition. It is unclear whether plasma miRNA levels correlate with platelet function. OBJECTIVE: To link small RNAs to platelet reactivity. ...
Hoefer, T; Armstrong, PC; Finsterbusch, M; Chan, MV; Kirkby, NS; Warner, TD (2015-08-13)OBJECTIVE: Reduced antiplatelet drug efficacy occurs in conditions of increased platelet turnover, associated with increased proportions of drug-free, that is, uninhibited, platelets. Here, we detail mechanisms by which ...